Page 37 - Read Online
P. 37

Strassheim et al. Vessel Plus 2018;2:29  I  http://dx.doi.org/10.20517/2574-1209.2018.44                                            Page 9 of 22







































               Figure 3. Extracellular ATP up regulates HIF-1a and HIF-2a transcription factors in pulmonary artery vasa vasorum endothelial cells.
               A, B: ATP (10 μmol/L), applied to VVEC, results in activation of both HIF-1a and HIF-2a with distinct time courses. VVEC were serum
               starved for 18 h and stimulated for indicated times. Nuclear fractions were subjected for Western blot analysis for HIF-1a, HIF-2a, and
               lamin A/C expression; C: cells were stained for HIF-1a at 1 h post stimulation with ATP (10 μmol/L), with or without PI3K inhibitor, PI-103
               pretreatment (0.5 μmol/L, 15 min). VVEC: vasa vasorum endothelial cells


               phages [41,171-174] .

               INFLAMMATION-DRIVEN ENDOTHELIAL DYSFUNCTION (ED) AS A MECHANISM OF VASCU-

               LAR REMODELING: INVOLVEMENT OF GPCRS
               Inflammatory stimuli, IL-1 or TNFa down-regulate eNOS, attenuate reparative angiogenesis, promote
               EC apoptosis, and increase endothelial to mesenchymal transition (EMT) - all of which contribute to
               ED [46,83,175,176] . TxA , acting on both ECs and VSMCs, is pathological in PH and inhibits VEGF- or FGF-
                               2
               2-promoted angiogenesis [46,147-149,165] . By contrast, many PH protective GPCR agonists (apelin, PGI ) increase
                                                                                                 2
                                                 1177
               eNOS activity by phosphorylation of Ser  or by increasing eNOS expression [50-52,177-179] . Some PH therapeu-
               tics, apelin and sildenafil, increase recruitment of endothelial cell progenitors, thereby counteracting ED [180-184] .

               THROMBOSIS AND PLATELET ACTIVITY CROSS TALK WITH VASCULAR INFLAMMATION AND
               GPCR ACTION
               Platelets from patients with the sub-form of PAH, due to thromboembolic PAH, exhibit increased reac-
               tivity to thrombin, which stimulates the G /G-coupled protease activated receptor 1 (PAR1), promoting
                                                     q
                                                       i
               VSMC proliferation [185,186] . Thrombin receptors exist on EC and have been reported to inhibit angiogenesis.

               RV REMODELING AND FAILURE
               Cardiac myocytes (CMs) are terminally differentiated cells. The compensatory cardiac hypertrophy is en-
   32   33   34   35   36   37   38   39   40   41   42